Scott Michael Habig is Chief Commercial Officer of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 456,338 shares of AUPH, which is worth approximately $3.29 Million. The most recent transaction as insider was on Aug 06, 2024, when has been sold 18,249 shares (Common Stock) at a price of $5.31 per share, resulting in proceeds of $96,902. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 456K
3.85% 3M change
45.93% 12M change
Total Value Held $3.29 Million

Scott Michael Habig Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 06 2024
SELL
Open market or private sale
$96,902 $5.31 p/Share
18,249 Reduced 3.85%
456,338 Common Stock
Mar 06 2024
SELL
Open market or private sale
$99,551 $5.6 p/Share
17,777 Reduced 3.61%
474,587 Common Stock
Feb 20 2024
SELL
Open market or private sale
$86,951 $5.48 p/Share
15,867 Reduced 3.12%
492,364 Common Stock
Feb 20 2024
BUY
Grant, award, or other acquisition
-
195,512 Added 27.78%
508,231 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
170,188 Added 35.24%
312,719 Common Stock
Nov 09 2022
BUY
Open market or private purchase
$25,050 $5.01 p/Share
5,000 Added 50.0%
5,000 Common Stock
SMH

Scott Michael Habig

Chief Commercial Officer
Victoria, A1

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Track Activities on AUPH